Acute Interstitial Nephritis, Acute Tubular Injury, and Drug-Induced Phospholipidosis Associated with Combined KRAS G12C and RAF/MEK Inhibition in Non-Small Cell Lung Cancer

Read full text Summarise with VIRAT
Authors: Jose Arriola‐Montenegro, Poemlarp Mekraksakit, Sam T. Albadri, Maria L. Gonzalez Suarez
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Targeted therapies directed against oncogenic KRAS mutations have significantly improved outcomes in non–small cell lung cancer (NSCLC), yet the renal safety profile of combined KRAS pathway inhibition remains incompletely defined. We report the case of a 60-year-old woman with metastatic KRAS G12C–mutated NSCLC who developed acute kidney injury following treatment with adagrasib, a selective KRAS G12C inhibitor, in combination with avutometinib, a dual RAF/MEK inhibitor. Kidney biopsy demonstrated acute interstitial nephritis with concomitant acute tubular injury. Ultrastructural evaluation revealed prominent lamellated myelin-like inclusions within podocytes, tubular epithelial cells, and mesangial cells, consistent with drug-induced phospholipidosis, without immune complex deposition. An extensive serologic evaluation was unrevealing. Discontinuation of both agents and initiation of corticosteroid therapy resulted in complete recovery of kidney function. This case suggests an expanded spectrum of renal injury associated with MAPK pathway–targeted therapies and highlights a previously unreported ultrastructural manifestation of combined KRAS G12C and RAF/MEK inhibition. As use of these agents increases, heightened awareness of potential nephrotoxicity and early multidisciplinary evaluation are essential to facilitate timely diagnosis and reversibility.

Fields of Study & Subjects

Acute Kidney Injury Research Lung Cancer Treatments and Mutations Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Case Reports
Volume
1
Issue
1
Pages
100018–100018
Publication date
1 March 2026
Language
EN